Topic: Bayer AG

UK's NICE again rejects Bayer liver cancer drug

LONDON (Reuters) - Britain's healthcare cost-effectiveness watchdog has again rejected Bayer's drug Nexavar for treating liver cancer on the state health service, despite a revised charging scheme from the company. Wednesday's decision is a setback for Bayer and its partner Onyx Pharmaceuticals, ...

Onyx sues Bayer over anti-cancer compound

NEW YORK (Reuters) - Onyx Pharmaceuticals Inc <ONXX.O> said on Sunday it sued Bayer AG <BAYG.DE> over its rights to an anti-cancer compound that it says it discovered during joint research with the German drugmaker. Onyx's lawsuit, filed in the U.S. District ...